Ramping
As a general rule the best way to start an HGH program is to start with a low dose and ease the administration into the higher doses. This will avoid, or at least minimize, many of the common side effects of HGH such as bloating, joint pain and swelling. Most people can tolerate approximately 2 i.u.'s with few side effects, so that would be the recommended starting dose. A scheduled program would look like this:
Week 1-4: HGH 2i.u.'s one injection
Week 5: HGH 2.5 i.u.'s one injection
Week 6: HGH 3 i.u.'s split into two injections of 1.5 i.u.'s each
Week 7: HGH 3.5 i.u.'s split into two injections of 1.75 i.u's each
And so forth until you reach your desired dose.
If at any point in this progression unbearable bloating or joint pain becomes an issue, the dose must be reduced by 25% and held at a lower dosage for a couple of weeks. If the side effects subside, progression may resume back up towards desired level. If the side effects remain, the dose must be reduced again and held at a lower level for two weeks before beginning upward progression. This method will keep the HGH experience a good one with minimal side effects.
Duration
As for the duration of a cycle of growth hormone, it is believed by many that the compound must be administered for a minimum of 20 to 30 weeks to see results. The action of the compound is slow acting and therefore lengthy cycles are needed. However due to its relative safety it can be run for several months, and even years, with little to no negative results. Of course this is dependent on the user and his or her individual reaction to the compound, along with the doses that they are using.
Administration
Human growth hormone can be administered using either intra-muscular or subcutaneous injections. There is no difference in the absorption of the compound.
Post Cycle Therapy
No type of post-cycle therapy is necessary when discontinuing growth hormone as it should continue to be produced naturally by the body of the user. The negative feedback loop that indicates to the body that there is enough of the hormone circulating is related to insulin-like growth factor. Specifically, when insulin-like growth factor is secreted by the liver a signal is sent to the pituitary gland and hypothalamus to cease the production of growth hormone6 .
Although not necessary, some opt to use growth hormone peptides to help promote their release of natural growth hormone.
Side Effects and Risks
For the most part, human growth hormone is a relatively mild compound with little in the way of side effects when compared to anabolic steroids.
The most common side effects experienced by users are sleepiness, bloating and/or joint pain. hGH improves sleep quality by a large margin, but when first taking it, it's not uncommon to feel intermittent sleepiness throughout the day like you want to take a nap.
The majority of users anecdotally report that any joint pain they experience most often ceases after a few weeks of administration of the drug2 .
In addition, at extreme high doses and long durations, it's possible to induce enlarged organs, carpal tunnel syndrome and acromegaly, which is a thickening of or abnormal growth of the bones7 . Think of Andre the Giant. For this reason, it would be advisable for users that are in their mid-to-late 20's or younger to consult with a physician if they're planning on administering growth hormone. This is due to the fact that if the growth plates of a user aren't yet fused, there's a potential for disproportionate bone growth. If there's a chance that a user has cancer or other tumours, it's imperative they ensure that they don't begin administering growth hormone prior to getting medically cleared. This is due to the fact that hGH can accelerate tumor growth rates.
Some users may also experience some other conditions related to use of growth hormone. Thyroid suppression, insulin resistance, and prostate growth are all possible side effects that could be experienced. There are various methods to help deal with these occurrences, ranging from the mild to the very aggressive. This profile will not go into great detail about these therapies, however it should be noted that most users are unlikely to have major difficulties with these side effects if their doses remain relatively moderate.
Human growth hormone has also been shown to cause gynocomastia in some users. The exact mechanism that this occurs is not know, however it is believed to be related to either the a rise in prolactin levels or else the growth hormone causes breast tissue growth when coupled with a high level of estrogen in the body. To combat this, the usual protocol can be used, i.e. use of aromatase inhibitors, selective estrogen receptor modulator and/or compounds that help to reduce prolactin levels.
Does using HGH shut down natural HGH production?
Answer:
The mechanism by which chronic exposure to hGH leads to tolerance, dependence, and a withdrawal syndrome is unclear and does not involve the suppression of hormone secretion. During the nadir of growth velocity, which follows the withdrawal of prolonged drug therapy, serum GH levels remain normal, as do serum IGF-I and IGF-binding protein-3 levels (4). Moreover, endogenous pulsatile secretion of GH resumes within days even after long-term hGH therapy (7).
http://press.endocrine.org/doi/full/...jcem.87.8.8721
HGH Brands List
Only brands listed here are the only HGH brands that are the exception to our "No Source Talk" rule. If your brand isn't listed there just refer to it as "generic HGH."
Brand Amino Acid Purity Available Since Manufacturer (Country)
Ansomone 191 medium 2005 Anke Biotechnology (China)
Fitropin 192 low 2008 - 2010 Kexing Biotech (China)
Genotropin 191 high 1996 Pfizer (USA)
Humatrope 191 high 1998 Eli Lilly (USA)
Hygetropin 191 medium 2008 Zhongshan Hygene Biopharm (China)
Hypertropin 191 high 2007 Neogenica Bioscience (China)
Jintropin 191 high 1997 GeneScience Pharmaceuticals (China)
Norditropin 191 high 1997 Novo Nordisk (USA)
Nutropin 191 high 1997 Genentech (USA)
Scitropin 191 medium 2005 SciGen (Singapore)
Saizen 191 high 1997 Merck Serono (Switzerland)
Serostim 191 high 2002 EMD Serono (USA)
Tev-Tropin 191 medium 2001 Teva Pharmaceuticals (USA)
Zomacton 191 medium 2002 Ferring Pharmaceuticals (Australia)
Zorbtive 191 high 2003 EMD Serono (USA)